Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder
FDA product code QCI · 9 cleared devices
- Regulation
- 21 CFR 882.5802
- Review panel
- NE
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2019-03-08 – 2026-06-03
External device that uses magnetic fields to induce neural activity in the cerebral cortex to treat neurological and psychiatric disorders and conditions. It is not intended for applying or focusing magnetic fields towards brain areas outside cerebral cortex (e.g., cerebellum).
Ultimate rTMS for OCD (M-series)
View details →BTL-99-OC
View details →CloudTMS Edge for OCD
View details →OCD MT Cap (85-00397-000)
View details →CloudTMS for OCD
View details →NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar
View details →MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy system
View details →Brainsway Deep TMS System
View details →No matching devices.
Advertisement